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Abstract 30	
Introduction: The STrengthening the Reporting of OBservational studies in Epidemiology 31	
(STROBE) guideline was developed in response to inadequate reporting of observational studies. 32	
In recent years, several extensions to STROBE have been created to provide more nuanced field-33	
specific guidance for authors. The content and the prevalence of extension endorsement has not 34	
yet been assessed. Accordingly, there are two aims: 1) to classify changes made in the extensions 35	
to identify strengths and weaknesses of the original STROBE checklist; and 2) to determine the 36	
prevalence and typology of endorsement by journals in fields related to extensions.  37	
Methods and analysis: Two independent researchers will assess additions in each extension. 38	
Additions will be coded as “field-specific” (FS) or “not field-specific” (NFS). FS is defined as 39	
particularly relevant information for a single field and guidance provided generally cannot be 40	
extrapolated beyond that field. NFS is defined as information that reflects epidemiological or 41	
methodological tenets and can be generalized to most, if not all, types of observational research 42	
studies. Intra-class correlation (ICC) will be calculated to measure reviewers’ concordance. 43	
Upon disagreement, consensus will be sought. Individual additions will be grouped by STROBE 44	
checklist items to identify the frequency and distribution of changes.  45	
Journals in fields related to extensions will be identified through National Library of Medicine 46	
(NLM) PubMed Broad Subject Terms, screened for eligibility, and further distilled via Ovid 47	
MEDLINE search strategies for observational studies. Text describing endorsement will be 48	
extracted from each journal’s website. A classification scheme will be created for endorsement 49	
types and the prevalence of endorsement will be estimated. Analyses will utilize NVivo 11 and 50	
SAS University Edition. 51	
Ethics and dissemination: This study does not require ethical approval as it does not involve 52	
human participants. This study has been pre-registered on Open Science Framework. 53	
Word count: 290 54	
Keywords: Reporting guidelines, STROBE, observational studies, information 55	
dissemination/methods, bibliometrics  56	
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Strengths and limitations of this study 57	
• Our systematic approach to qualitatively assess the content of the additions made in the 58	
STROBE extensions provides a comprehensive overview of the types of changes made 59	
and can identify redundancies and problem areas. 60	
• Our method involves standardized search strategies in Ovid MEDLINE, ensured to 61	
capture a representative sample and circumvent issues of subjectivity in the identification 62	
of eligible journals  63	
• This study will create an open source corpus of recent observational studies spanning 64	
seven fields which future researchers can utilize to assess completeness of reporting or 65	
other topics of interest.  66	
• The bibliometric aspect of this study only focuses on 7 extensions and fields so results 67	
are not generalizable to other studies.   68	
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INTRODUCTION 69	
The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) 70	
guidelines were developed in 2007 in response to the pervasiveness of inadequate reporting of 71	
observational studies. STROBE provides a checklist of items that serve as a reference for how to 72	
report sufficient information for observational research involving cohort, case-control, and cross-73	
sectional studies [1]. The guidelines have been endorsed by the International Committee of 74	
Medical Journal Editors (ICMJE) and the accompanying checklist is sometimes explicitly used 75	
as a requirement for manuscript submission [2]. However, there is no standard method of 76	
endorsement by journals and little is known about the most effective ways to apply the 77	
guidelines in practice [3–5]. 78	
Regarding the reporting of clinical trials, requiring a completed Consolidated Standards 79	
of Reporting Trials (CONSORT) checklist upon submission of a manuscript has been shown to 80	
lead to improvements in reporting [6]. However, some journals do not want to take responsibility 81	
for guideline enforcement and many overlook non-adherence to guidelines; editors have 82	
expressed beliefs that their journal’s current policies are adequate or that they fear losing authors 83	
to other journals that have less strict requirements for publication [7–9]. Editors may also be 84	
unaware of the existence of guidelines, as demonstrated by low endorsement rates by journals in 85	
dentistry [10], veterinary medicine [7], and urology [11]. On the other hand, the evidence for the 86	
endorsement of STROBE is also mixed. Endorsement was not shown to be associated with better 87	
reporting for items related to confounding, regardless of strength [12]. 88	
Several field-specific extensions to STROBE have been designed in recent years in an 89	
effort to promote complete reporting, provide more nuanced guidance for authors, and perhaps 90	
address editor’s concerns that STROBE is not focused enough for their journal. Extensions for 91	
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other reporting guidelines are common, however the creation of extensions for STROBE seems 92	
to outpace those for other reporting guidelines such as the CONSORT [13]. Since the publication 93	
of STROBE in 2007, 13 extensions have been published and indexed by the Enhancing the 94	
QUAlity and Transparency Of health Research (EQUATOR) Network, an international 95	
collaboration that promotes transparent and accurate reporting and indexes reporting guidelines 96	
[14]. In contrast, CONSORT was first published in 1996, updated in 2001 and further revised in 97	
2010, yet only 17 extensions have been published during that period [15]. The reason behind the 98	
difference in the pacing of publications of extensions is unclear. Perhaps the concept of field-99	
specific extensions to reporting guidelines were pioneered by CONSORT, thus making the idea 100	
more commonplace for subsequent reporting guidelines. Alternatively, the complexity of the 101	
types of observational research studies may require more guidance due to the wide variety of 102	
methods employed in observational studies. Regardless of the reasoning, it is evident that authors 103	
are still perceiving a need to provide more guidance on how to report information about their 104	
studies. However, until now, many of these initiatives have not been evaluated.  105	
Extensions to STROBE offer a potential new avenue for promoting more complete 106	
reporting but their use has been largely unassessed and, similar to STROBE, they may face 107	
implementation and usage problems [3,7]. Being intended as general guidelines for observational 108	
studies, STROBE should include necessary information that is sufficient to most observational 109	
studies. For some fields, however, STROBE guidelines may not be sufficient due to specific 110	
requirements within the field. This gap is then covered by an extension for that field. However, 111	
when extensions include non-specific guidance that can be extrapolated to most observational 112	
studies (e.g. details about participants, settings, confounders, follow-up, biases or any other 113	
general epidemiological constructs), it suggests potential deficiencies in STROBE checklist. If 114	
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the content is already in STROBE, extension authors may have thought that it was not clearly 115	
communicated, or that it is necessary to include it in the checklist instead of being only in the 116	
explanation and elaboration document. Whilst, if the content is not already in STROBE, 117	
extension authors may have identified a gap or insufficiency which should be considered as an 118	
addendum to STROBE. Therefore, by identifying non-specific or redundant guidance suggested 119	
in the STROBE extensions, we will be able to identify perceived gaps and deficiencies in the 120	
current STROBE checklist and potentially reduce future waste in the process of extension 121	
creation. 122	
A perceived lack of confidence in reporting guidelines can impact journal editors’ 123	
willingness to endorse reporting guidelines. Currently, it is unclear if and how journals are 124	
encouraging or requiring authors to use STROBE extensions. As journals are key players 125	
influencing the use and uptake of extensions, the prevalence and typology of extension 126	
endorsement is needed to understand the variety of methods employed to encourage transparent 127	
reporting. Data collected from this study can later be used as the groundwork for an evaluation of 128	
the impact of endorsement on the completeness of reporting.  129	
Aims 130	
The objectives of this study are twofold. Firstly, to qualitatively assess and classify the 131	
changes made in the extensions to help to identify the strengths and weaknesses of the original 132	
STROBE checklist; this will identify potential problem areas or deficiencies conveyed in 133	
extension additions. Secondly, we will estimate the prevalence of endorsement in journals that 134	
publish observational studies from extension-related fields and create an endorsement typology 135	
to provide a finer detailed view of the promotion of the STROBE extensions.  136	
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 METHODS AND ANALYSIS  137	
Qualitative Assessment and Analysis 138	
The main focus of this phase will be on coding the additions that are made in each 139	
extension. Coded additions will help to identify the strengths, weaknesses and redundancies 140	
conveyed in the STROBE extensions in order to provide guidance for modifications to the 141	
original STROBE checklist and to identify target areas for future educational interventions. 142	
We will assess the content of 13 STROBE extensions which were identified through the 143	
EQUATOR Network website as well as through a PubMed search for STROBE-related 144	
publications. Two independent reviewers (DH, MKS) will code the additions made in each 145	
STROBE extension; disagreement will be resolved by consensus. Each sub-item on an extension 146	
that is attached to a STROBE checklist item will be coded individually by the relevant content 147	
area (e.g., item 5 sub-item additions a, b, and c, will be counted and coded as three separate 148	
items). Each sub-item will also be coded as “field-specific” (FS) or “not field-specific” (NFS). 149	
FS is defined as information that is particularly relevant for a single field and guidance provided 150	
cannot be generalized beyond that particular extension’s field. Items which note phrases such as 151	
“including,” “specifically,” “for example,” and “e.g.” followed by a field-specific example, 152	
generally are considered to be field-specific as these items are adding additional information 153	
specific to a certain topic area. NFS is defined as information that reflects general 154	
epidemiological or methodological tenets and can be extrapolated to most, if not all, types of 155	
observational research studies. 156	
For the subjective assessments of the field-specific or not field-specific nature of the 157	
additions (rated as binary yes or no), intra-class correlation (ICC) will be used to assess the inter-158	
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rater reliability (IRR). The ICC for the two raters will be calculated for ratings across all 13 159	
extensions that involve the subjective assessment of an item as field-specific or not. This method 160	
was chosen because ICC does not take an all-or-nothing approach to agreement but rather it 161	
“incorporates the magnitude of disagreement to compute IRR estimates” [16]. Descriptive 162	
statistics such as counts, means, and percentages will be given. 163	
Endorsement Survey 164	
Eligibility Criteria 165	
Extensions to the STROBE guidelines were identified through the EQUATOR Network 166	
website as well as through a search on PubMed. Extensions are eligible for assessment if at least 167	
one year has passed since publication as this allows for some time for endorsement and 168	
implementation. In the case of multiple publications of an extension, the earliest 169	
publication/availability date will be used to determine eligibility. As of March 1, 2017, eligible 170	
extensions are detailed in Table 1 while ineligible extensions are detailed in Table 2. 171	
Table 1. Extensions Eligible for Assessment 172	
Abbreviation Title/Description Publication Date 
STREGA [4] STrengthening the REporting of Genetic Association Studies February 3, 2009 
STROBE-
EULAR [17]* A EULAR extension of STROBE guidelines June 4, 2010 
STROBE-ME 
[18] 
STrengthening the Reporting of OBservational studies 
in Epidemiology - Molecular Epidemiology October 24, 2011 
STROME-ID 
[19] 
Strengthening the Reporting of Molecular 
Epidemiology for Infectious Diseases   March 13, 2014 
STROBE-RDS 
[20] 
Strengthening the Reporting of Observational Studies 
in Epidemiology for Respondent-Driven Sampling 
studies 
May 1, 2015 
RECORD 
[21] 
REporting of studies Conducted using Observational 
Routinely-collected health Data (RECORD) 
Statement  
October 6, 2015 
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STROBE-AMS 
[22] 
Strengthening the Reporting of Observational Studies 
in Epidemiology for AntiMicrobial Stewardship February 19, 2016 
* This extension does not have an official acronym. For simplicity’s sake, this will be used. 173	
 174	
Table 2. Extensions Not Eligible for Assessment 175	
Abbreviation Title/Description Publication Date 
MARE-S [23] Medical Abortion Reporting of Efficacy - STROBE April 23, 2016 
STROBE-NUT 
[24] 
Strengthening the Reporting of Observational Studies 
in Epidemiology-NUTritional epidemiology  
June 7, 2016 
ROSES-I [25] CONSISE statement on the REporting of 
SEroepidemiologic Studies for influenza 
July 17, 2016 
STROBE-SBR 
[26] 
Strengthening the Reporting of Observational Studies 
in Epidemiology for Simulation-Based Research 
July 26, 2016 
STROBE-NI 
[27] 
Strengthening the Reporting of Observational Studies 
in Epidemiology for Newborn Infection 
September 13, 2016 
STROBE-Vet 
[28] 
Strengthening the Reporting of Observational Studies 
in Epidemiology – Veterinary 
November 1, 2016 
	176	
Identification of Journals 177	
Journals in fields related to extensions will be identified using the National Library of 178	
Medicine (NLM) Catalog which contains, among other things, “biomedical and health-related 179	
life sciences journals” indexed in MEDLINE. As of March 2017, there are over 5,600 journals 180	
indexed [29]. This database was chosen for two primary reasons: 1) Broad Subject Terms are 181	
used which allows for easy identification and segmentation of research fields for journals and 182	
topic areas for articles; and 2) the segmentation of other search engines, namely Clarivate 183	
Analytics Web of Science Journal List [30], did not clearly align with extension fields and would 184	
result in more overwhelming searches with less certainty that potentially eligible journals would 185	
be identified.  186	
Journals will be identified using the following search string in the NLM Catalog: 187	
pubmed[“Broad subject terms”]. If an extension reports search terms in their publication, these 188	
will be considered as a starting point. All search strategies were developed in collaboration with 189	
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a medical librarian. Further details listing the individual broad subject terms used for each 190	
extension are detailed in Table 3.  191	
Table 3. Broad Subject Terms  192	
STROBE Extension Broad Subject Term(s) 
STREGA Genetics, Genetics, Medical 
STROBE-EULAR Rheumatology 
STROBE-ME Molecular Biology 
STROME-ID Molecular Biology, Anti-Infective Agents 
STROBE-RDS Public Health 
RECORD Health Services, Health Services Research 
STROBE-AMS Anti-Infective Agents, Drug Therapy 
 193	
Screening 194	
Journals will be manually screened to confirm that they publish in English, are in a 195	
relevant format (e.g., not a textbook, magazine, etc.), and are currently publishing. From the 196	
remaining list of journals that are indexed in MEDLINE, search strategies will be used to 197	
identify observational studies in the relevant topic areas (see Supplementary File 1). The filter 198	
for observational studies is a combination of a study design search filter for cohort and case-199	
control studies by BMJ Evidence Centre information specialists, Fraser et al.’s work on 200	
identifying observational studies in surgical interventions, and consultations with a medical 201	
librarian [31,32].  202	
From the remaining list of journals that publish observational studies, field-specific 203	
search strategies (detailed in Supplementary File 1) will be used. Extensions were used as a 204	
starting point and extant systematic reviews provided additional guidance, particularly for 205	
RECORD and STROBE-AMS [33,34]. In the case of EULAR, a combination approach will not 206	
be used as this is the only extension where the broad subject term is the exact focus of the 207	
extension; the search strategy for observational studies will still be used.  208	
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The results of the OVID MEDLINE field-specific and observational search strategies will 209	
be compared to the list of journals that the search was run on to determine inclusion and 210	
exclusion.  This combination approach will be used for several reasons. Firstly, journal 211	
information from NLM is given in more structured manner and allows for easy matching 212	
between sets with overlapping Broad Subject Terms. For example, both STROBE-AMS and 213	
STROME-ID use the term “Anti-Infective Agents” while both STROBE-ME and STROME-ID 214	
use “Molecular Biology.” This approach is also less resource-intensive and allows us to more 215	
easily identify how many journals in each field publish observational studies, thus establishing 216	
the extent and importance of the issue. 	217	
 218	
Data Extraction 219	
Eligible journals and their websites will be searched exhaustively for any mention of 220	
STROBE extensions in their instructions for authors, guidelines for reviewers, other guidance 221	
documents, or ethical policies. Data will be extracted by the first author (MKS). To inspect 222	
reliability, another researcher (DH) will extract data from 10% of the sample and agreement will 223	
be calculated. Primary data sources (i.e., website pages) will be downloaded in pdf format and 224	
relevant text describing guideline endorsement will be extracted and coded into a standard data 225	
extraction sheet in Excel. Although STROBE and its extensions are the main focus of this 226	
investigation, we will also collect information about endorsement of other common guidelines 227	
such as CONSORT, PRISMA, ICMJE’s Recommendations for the Conduct, Reporting, Editing, 228	
and Publication of Scholarly work in Medical Journals and mentions of organizations like 229	
EQUATOR and COPE [13,15,35–37]. This information will be gathered to see if journals that 230	
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endorse other reporting guidelines or ethical reporting guidance, are more likely to endorse 231	
STROBE or an extension.  232	
Altman and Hopewell’s classification schema will be used as a starting point for the 233	
development of a typology of endorsement for STROBE and extensions [6,38,39]. We anticipate 234	
that there will be several categories of endorsement ranging from strong to weak. Some 235	
examples include a requirement of a completed checklist with manuscript submission, a 236	
suggestion that authors “should” reference or follow a specific guideline, a vague suggestion that 237	
author should adhere to reporting guidelines, a vague suggestion that authors should adhere to 238	
certain standards which include reference to reporting guidelines, or not explicit mention at all. 239	
In addition to information regarding support for STROBE and its extensions, general 240	
information about the journal such as impact factor, publisher, and contact information for the 241	
editorial offices will be collected. For the purposes of future analyses focused on completeness 242	
of reporting, it will also be noted if journals have recently launched and have not been publishing 243	
for at least two years prior to the publication of its related extension; this will ensure the ability 244	
to establish baseline data on the completeness of reporting. For example, STREGA was 245	
published in 2009, therefore journals must have begun publishing by 2007 to be included in latter 246	
assessments.	247	
As publishers often provide additional resources for authors, we will collect information 248	
from the websites of publishers about their methods of endorsement. Endorsement from 249	
publishers will be considered to be indirect methods of support as they require significant effort 250	
on the part of the user seeking the information. Information communicated directly through the 251	
journal’s website will be considered to be direct if it is supplied in immediately available 252	
resources to authors. 253	
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 254	
Statistical Analyses 255	
Endorsement, types of endorsement, and journal characteristics (e.g. Impact factor, 256	
publisher) will be expressed using descriptive statistics such as counts, means/medians, and 257	
percentages. For analyses comparing two binary variables (i.e., endorsement of extensions and 258	
endorsement of other reporting guidelines), unadjusted odds ratios and their associated 95% 259	
confidence intervals will be conducted. Differences in impact factors between endorsing and 260	
non-endorsing journals will be assessed with the Wilcoxon test of ranks, equivalent to the c-stat, 261	
c-index or area under the receiver operating characteristic (ROC) curve. All confidence intervals 262	
will be provided at the two-sided 95% level.  263	
 264	
DISCUSSION  265	
An evaluation of the extensions provides a deeper understanding of content areas that are 266	
adequately detailed or in need of elaboration. By identifying the content areas that authors have 267	
difficulties with, the groundwork will be laid for an assessment into how authors currently use 268	
and understand STROBE and what difficulties they encounter with its implementation. This 269	
study will provide us with potential hypotheses for future survey for authors, focused both on the 270	
perceived sufficiency of STROBE and the extensions as this could be a barrier to use. For 271	
example, if we find non-specific additions in parts of STROBE, we may focus on those parts 272	
when inquiring authors' opinions about adequacy of STROBE. The qualitative assessment will 273	
also allow us to identify key areas (e.g., particular sections of the methods, results, conclusion) 274	
that may be commonly misunderstood to specifically probe authors about these points.  275	
Results from this study will also provide estimates of the frequency and typology of 276	
endorsement. This dataset will allow journals to be targeted in order to promote guideline usage 277	
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and will establish a groundwork for follow-up studies on attitudes related to endorsement of 278	
STROBE and its extensions. Perhaps most importantly, this study will provide the foundation for 279	
assessing the impact that endorsement has on the completeness of reporting. The data collected 280	
through this study will generate important insights for the design of future studies such as 281	
feasibility or pilot studies to estimate the effects of endorsement. Perceived lack of tangible 282	
benefit due to a weak evidence-base can be a major barrier to guideline use. Testing a 283	
relationship between endorsement and an increase in completeness of reporting, can provide the 284	
much-needed data to address skeptic’s concerns about the tangible value of supporting STROBE 285	
and its extensions.  286	
This study will solidify the scope of the problem of insufficient support and use of 287	
STROBE extensions, detail variability in endorsement typology, and establish data for future 288	
studies focused on the effects of endorsement on completeness of reporting and attitudes towards 289	
STROBE and its extensions.  290	
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